Intermittent dobutamine therapy in patients with advanced congestive heart failure

Archives of Gerontology and Geriatrics

Volumn 23, Issue 3, 1996, Pages 313-327

  Ferroni, Claudio ^a   Fraticelli, Aureliano ^a   Paciaroni, Enrico ^a  

^a INRCA   (Italy)

Author keywords

Congestive heart failure; Dobutamine therapy in elderly

Indexed keywords

DOBUTAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLUSHING; FOLLOW UP; HEADACHE; HEALTH CARE COST; HEART TRANSPLANTATION; HEART VENTRICLE EXTRASYSTOLE; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

EID: 0030294037     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4943(96)00739-X     Document Type: Article

References (28)

1. Applefeld, M.M., Newman, K.A., Grove, W.R., Sutton, F.J., Roffman, D.S., Reed, W.P. and Linberg, S.E. (1983): Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure. Am. J. Cardiol., 51, 455-458.
2. Applefeld, M.M., Newman, K.A., Sutton, F.J., Roffman, D.S., Talesnick, B.S. and Grove, W.R. (1987): Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients. Am. Heart J., 114, 589-595.
3. Berger, M. and McSherry, C.K. (1985): Outpatient dubutamine infusion using a totally implantable infusion pump for refractory congestive heart failure. Clin. Pharmacol., 88, 295-296.
4. Cohn, J.N., Levine, T.B., Francis, G.S. and Goldsmith, S. (1981): Neurohumoral control mechanisms in congestive heart failure. Am. Heart J., 102, 509-514.
5. Cohn, J.N., Archibald, D.J., Ziesche, S., Franciosa, J.A., Harston, W.E., Tristani, F.E., Bunkman, W.B., Jacobs, W., Francis, G.S. and Flohr, K.H. (1986): Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N. Engl. J. Med., 314, 1547-1552.
6. Collins, J.A., Skidmore, M.A., Melvin, D.B. and Engel, P.J. (1990): Home intravenous dobutamine therapy in patients awaiting heart transplantation. J. Heart Lung Transplant, 9, 205-208.
7. Dies, F., Krell, M.J., Whitlow, P., Liang, C., Goldenberg, I., Applefeld, M.M. and Gilbert, M. (1986): Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure. Circulation, 74 (Suppl. II), II-38 (abstract only).
8. Feldman, A.M., Bristow, M.R., Parmley, W.M, Carson, P.E., Pepine, C.J., Gilbert, E.M., Strobeck, J.E., Hendrix, G.H., Powers, E.R. and Bain, R.P. (1993): Effects of vesnarinone on morbidity and mortality in patients with heart failure. N. Engl. J, Med., 329, 149-155.
9. Goldenberg, I.F., Olivari, M.T., Levine, T.B. and Cohn, J.N. (1989): Effect of dobutamine on Plasma Potassium in congestive heart failure secondary to idiopathic or ischemic cardiomyopathy Am. J Cardiol., 63, 843-846.
10. Goldstein, R.A. (1989): Dobutamine in acute myocardial infarction. In: Dobutamine, pp. 83-95. Editor: K. Chatterjee. NMV Publishers, New York.
11. Hodgson, J.M., Aja, M. and Sorkin, R.P. (1984): Intermittent ambulatory dobutamine infusion for patient awaiting cardiac transplantation. Am. J. Cardiol., 15, 353-375
12. Krell, M.J., Kline, E.M., Bates, E.R., Hodgson, J.M., Dilworth, L.R., Laufer, N., Vogel, R.A. and Pitt, B. (1986): Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure. Am. Heart J., 112, 787-791.
13. Lawless, C.E. and Loeb, K.S. (1989): Pharmacokinetics and pharmacodynamics of dobutamine. In: Dobutamine, pp. 33-47. Editor: K. Chatterjee. NMV Publishers, New York.
14. Lejemtel, T.H., Katz, S.D. and Scortichini, D. (1989): Myocardial contractility and the effects of dobutamine on cardiac pump function. In: Dobutamine, pp. 69-79. Editor: K. Chatterjee. NMV Publishers, New York.
15. Liang, C.S., Sherman, L.G., Doherty, J.U., Wellington, K., Lee, V.W. and Hood, W.B. jr. (1984): Sustained improvement of cardiac function in patients with congestive heart failure after short term infusion of dobutamine. Circulation, 69, 113-119.
16. Miller, L.W., Merkle, E.J. and Herrmann, V. (1990): Outpatient dobutamine for end-stage congestive heart failure. Crit. Care Med., 18, 30-33.
17. NYHA (1973): Diseases of the heart and blood vessels. In: Criteria Committee of the New York Heart Association: Nomenclature and Criteria for Diagnosis, 7th Edition, pp. 286-289. Little Brown, Boston.
18. Oliva, F., Leonardi, G., Mafrici, A., Galli, M., Politi, A. and Mauri, F. (1994a): Assessment of secondary pulmonary hypertension reversibility in chronic heart failure patients evaluated for cardiac transplantation. Eur. Heart J., 14 (Suppl.), 366-370.
19. Oliva, F., Mafrici, A., Brucato, A., Politi, A., Calli, M., Ciglioli, C., Valente, S., Malesani, L., Opasich, C., Febo, O., Latini, R. and Mauri, F. (1994b): Terapia intermittente domiciliare con dubutamina in pazienti con insufficienza cardiaca cronica di grado avanzato. Studio multicentrico. Giorn. Ital. Cardiol., 24 (Suppl. I), 489 (abstract only) (in Italian).
20. Packer, M., Carver, J.R., Rodeheffer, R.J., Ivanhoe, R.J., DiBianco, R., Zeldis, S.M., Hendrix, G.H., Bommer, W.J., Elkayam, U. and Kukin, M.L. (1991): Effect of oral milrinone on mortality on severe chronic heart failure. The PROMISE Study Research Group. N. Engl. J. Med., 325, 1468-1475.
21. Richard, C., Ricome, J.L., Rimailho, A., Bottineau, G. and Auzepy, P. (1983): Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock. Circulation, 67, 620-627.
22. Sacher, H.L., Sacher, M.L., Landau, S.W., Araghi, A., Mene, M., Dooley, F. and Dietrich, K.A. (1992): Outpatient dobutamine therapy: the rhyme and the riddle. J. Clin. Pharmacol., 32, 141-147.
23. Tan, L.B. and Littler, W.A. (1990): Measurement of cardiac reserve in cardiogenic shock: Implications for prognosis and management. Brit. Heart J., 64, 121-128.
24. The CONSENSUS Trial Study Group (1987): Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N. Engl. J. Med., 316, 1429-1435.
25. Tsukahara, I. (1989): Amrinone and dobutamine in heart failure: acute effects on left ventricular function. Acta School Med. Univ. Gifu, 37, 1042-1054.
26. Unverferth, D.V., Blanford, M., Kates, R.E. and Leier, C.V. (1980): Tolerance to dobutamine after 72 hours continous infusion. Am. Heart J., 69, 262-266.
27. Unverferth, D.V., Magorien, R.D., Altshuld, R., Kolibash, A.J., Lewis, R.P. and Leier, C.V. (1983): The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy. Am. Heart J., 106, 29-34.
28. Wong, M., Johnson, G., Shabetai, R., Hughes, V., Bhat, G., Lopez, B. and Cohn, J.N. (1993): Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure. Veterans Affairs cooperative studies V-HeFT I and II. V-HeFT VA Cooperative Studies Group. Circulation, 87, V165-V170.